Business By Rebecca Robbins Documentarian Alex Gibney has taken on Enron, Scientology — and now Theranos
Biotech By Meghana Keshavan Theranos tries to quell doubts with new blood test platform, but shows scant data
Biotech By Meghana Keshavan Embattled Theranos promises first-ever peek at its science — but doubts abound
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Biogen CEO to leave, Theranos hires compliance execs
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Purdue delayed reporting excessive OxyContin prescribing
Business By Rebecca Robbins and Meghana Keshavan Theranos plans bold expansion even as it reels from new setbacks
Politics By Rebecca Robbins When does hyping a product become a criminal act? Theranos may be about to find out
Business By Rebecca Robbins Theranos CEO Elizabeth Holmes faces possible two-year ban from blood-testing industry
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Walgreens threatens to terminate Theranos partnership
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Roche internal investigation, problems at Theranos lab
Business By Rebecca Robbins The Theranos scandal should be a wake-up call. Here are 4 reasons it won’t be
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: US prices higher for top-selling drugs, FDA investigating Theranos